In a previous study, PBMCs (including blast cells) from AML patients had higher levels of TF procoagulant activity compared to PBMCs from ALL patients.[29] In addition, PBMCs from patients with APL had the highest levels of TF procoagulant activity compared to other subtypes of AML. Here, TF is linked to acute promyelocytic leukemia.